Coronavirus Disease 2019 (COVID-19): A Brief Report

Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followe...

Full description

Bibliographic Details
Main Author: Domenico Lorenzo Urso
Format: Article
Language:English
Published: SEEd 2020-04-01
Series:Clinical Management Issues
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467
_version_ 1818851828541947904
author Domenico Lorenzo Urso
author_facet Domenico Lorenzo Urso
author_sort Domenico Lorenzo Urso
collection DOAJ
description Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest. At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases. The present report summarizes the point of the situation about this global emergency.
first_indexed 2024-12-19T07:11:14Z
format Article
id doaj.art-83f04dae399d4ca3a70971c68861e732
institution Directory Open Access Journal
issn 2283-3137
language English
last_indexed 2024-12-19T07:11:14Z
publishDate 2020-04-01
publisher SEEd
record_format Article
series Clinical Management Issues
spelling doaj.art-83f04dae399d4ca3a70971c68861e7322022-12-21T20:31:11ZengSEEdClinical Management Issues2283-31372020-04-0114110.7175/cmi.v14i1.14671310Coronavirus Disease 2019 (COVID-19): A Brief ReportDomenico Lorenzo Urso0Emergency Department - Spoke Hospital Corigliano-Rossano (CS), ItalySevere acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest. At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases. The present report summarizes the point of the situation about this global emergency.https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467sars-cov-2coronaviruspandemicpneumoniarespiratory support
spellingShingle Domenico Lorenzo Urso
Coronavirus Disease 2019 (COVID-19): A Brief Report
Clinical Management Issues
sars-cov-2
coronavirus
pandemic
pneumonia
respiratory support
title Coronavirus Disease 2019 (COVID-19): A Brief Report
title_full Coronavirus Disease 2019 (COVID-19): A Brief Report
title_fullStr Coronavirus Disease 2019 (COVID-19): A Brief Report
title_full_unstemmed Coronavirus Disease 2019 (COVID-19): A Brief Report
title_short Coronavirus Disease 2019 (COVID-19): A Brief Report
title_sort coronavirus disease 2019 covid 19 a brief report
topic sars-cov-2
coronavirus
pandemic
pneumonia
respiratory support
url https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1467
work_keys_str_mv AT domenicolorenzourso coronavirusdisease2019covid19abriefreport